110 related articles for article (PubMed ID: 36052503)
21. H3K27 trimethylation loss in malignant peripheral nerve sheath tumor: a systematic review and meta-analysis with diagnostic implications.
Lu VM; Marek T; Gilder HE; Puffer RC; Raghunathan A; Spinner RJ; Daniels DJ
J Neurooncol; 2019 Sep; 144(3):433-443. PubMed ID: 31342317
[TBL] [Abstract][Full Text] [Related]
22. The Role of Polycomb Repressive Complex in Malignant Peripheral Nerve Sheath Tumor.
Zhang X; Murray B; Mo G; Shern JF
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32182803
[TBL] [Abstract][Full Text] [Related]
23. Cytogenetic analysis of a malignant triton tumor and a malignant peripheral nerve sheath tumor and a review of the literature.
McComb EN; McComb RD; DeBoer JM; Neff JR; Bridge JA
Cancer Genet Cytogenet; 1996 Oct; 91(1):8-12. PubMed ID: 8908161
[TBL] [Abstract][Full Text] [Related]
24. Malignant peripheral nerve sheath tumor: The need to get it right first time around.
Brennan B
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29115724
[No Abstract] [Full Text] [Related]
25. H3K27me3 expression and methylation status in histological variants of malignant peripheral nerve sheath tumours.
Lyskjaer I; Lindsay D; Tirabosco R; Steele CD; Lombard P; Strobl AC; Rocha AM; Davies C; Ye H; Bekers E; Ingruber J; Lechner M; Amary F; Pillay N; Flanagan AM
J Pathol; 2020 Oct; 252(2):151-164. PubMed ID: 32666581
[TBL] [Abstract][Full Text] [Related]
26. Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Jones J; Cain S; Pesic-Smith J; Choong PFM; Morokoff AP; Drummond KJ; Dabscheck G
J Neurooncol; 2021 Sep; 154(3):265-274. PubMed ID: 34529228
[TBL] [Abstract][Full Text] [Related]
27. [Targeted therapy for malignant peripheral nerve sheath tumor: translational research and clinical application].
Liao ZC; Zhang C; Liu XY; Ren ZW; Xu J; Zhang CZ; Yang Y; Zhu Z; Yang JL
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):648-653. PubMed ID: 31550853
[TBL] [Abstract][Full Text] [Related]
28. Assessment of H3K27me3 immunohistochemistry and combination of NF1 and p16 deletions by fluorescence in situ hybridization in the differential diagnosis of malignant peripheral nerve sheath tumor and its histological mimics.
Sugita S; Aoyama T; Emori M; Kido T; Takenami T; Sakuraba K; Terai K; Sugawara T; Tsujiwaki M; Hasegawa T
Diagn Pathol; 2021 Aug; 16(1):79. PubMed ID: 34461930
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and prognostic significance of H3K27 methylation status in malignant peripheral nerve sheath tumor: correlation with skeletal muscle differentiation.
Ito Y; Kohashi K; Endo M; Yoshimoto M; Ishihara S; Toda Y; Susuki Y; Kawaguchi K; Furukawa H; Tateishi Y; Yamada Y; Kinoshita I; Mori T; Yamamoto H; Nakashima Y; Oda Y
Virchows Arch; 2021 Dec; 479(6):1233-1244. PubMed ID: 34432163
[TBL] [Abstract][Full Text] [Related]
30. Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives.
Widemann BC; Italiano A
J Clin Oncol; 2018 Jan; 36(2):160-167. PubMed ID: 29220302
[TBL] [Abstract][Full Text] [Related]
31. Primary malignant peripheral nerve sheath tumors of bone: a clinicopathologic reappraisal of 8 cases.
Gambarotti M; Righi A; Sbaraglia M; Cocchi S; Benini S; Magagnoli G; Frisoni T; Palmerini E; Picci P; Dei Tos AP
Hum Pathol; 2022 Apr; 122():92-102. PubMed ID: 35176251
[TBL] [Abstract][Full Text] [Related]
32. Selinexor, a First in Class, Nuclear Export Inhibitor for the Treatment of Advanced Malignant Peripheral Nerve Sheath Tumor.
Al-Ezzi E; Gounder M; Watson G; Mazzocca A; D'Angelo SP; Bravetti J; Wang H; Abdul Razak A; Vincenzi B
Oncologist; 2021 Apr; 26(4):e710-e714. PubMed ID: 33512749
[TBL] [Abstract][Full Text] [Related]
33. The genetic predisposition to and histogenesis of neurofibromas and neurofibrosarcoma in neurofibromatosis type 1.
Riccardi VM
Neurosurg Focus; 2007 Jun; 22(6):E3. PubMed ID: 17613220
[TBL] [Abstract][Full Text] [Related]
34. Mxi1 mutations in human neurofibrosarcomas.
Li XJ; Wang DY; Zhu Y; Guo RJ; Wang XD; Lubomir K; Mukai K; Sasaki H; Yoshida H; Oka T; Machinami R; Shinmura K; Tanaka M; Sugimura H
Jpn J Cancer Res; 1999 Jul; 90(7):740-6. PubMed ID: 10470286
[TBL] [Abstract][Full Text] [Related]
35. RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors.
Kohlmeyer JL; Kaemmer CA; Pulliam C; Maharjan CK; Samayoa AM; Major HJ; Cornick KE; Knepper-Adrian V; Khanna R; Sieren JC; Leidinger MR; Meyerholz DK; Zamba KD; Weimer JM; Dodd RD; Darbro BW; Tanas MR; Quelle DE
Clin Cancer Res; 2020 Jun; 26(12):2997-3011. PubMed ID: 32086342
[TBL] [Abstract][Full Text] [Related]
36. Gene of the month: H3F3A and H3F3B.
Aldera AP; Govender D
J Clin Pathol; 2022 Jan; 75(1):1-4. PubMed ID: 34782425
[No Abstract] [Full Text] [Related]
37. [Primary malignant peripheral nerve sheath tumor in left orbit: a case report].
Wang YQ; Wang R; Shi D; Lu K; Jin D; Xu L; Fan GH; Shen JK; Gong JP; Qian MH
Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):509-510. PubMed ID: 33902216
[No Abstract] [Full Text] [Related]
38. Endogenous Retroelements and the Viral Mimicry Response in Cancer Therapy and Cellular Homeostasis.
Chen R; Ishak CA; De Carvalho DD
Cancer Discov; 2021 Nov; 11(11):2707-2725. PubMed ID: 34649957
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of malignant peripheral nerve sheath tumors: case reports and a literature review].
Konovalov NA; Korolishin VA; Asyutin DS; Timonin SY; Shults MA; Solenkova AV; Zakirov BA; Batyrov AA
Zh Vopr Neirokhir Im N N Burdenko; 2019; 83(3):64-72. PubMed ID: 31339498
[TBL] [Abstract][Full Text] [Related]
40. Identification of a novel fusion transcript EWSR1-VEZF1 by anchored multiplex PCR in malignant peripheral nerve sheath tumor.
Benini S; Gamberi G; Cocchi S; Righi A; Frisoni T; Longhi A; Gambarotti M
Pathol Res Pract; 2020 Jan; 216(1):152760. PubMed ID: 31812440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
